500288 Stock Overview
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 500288 from our risk checks.
Morepen Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹42.06 |
52 Week High | ₹56.35 |
52 Week Low | ₹25.20 |
Beta | 1.27 |
1 Month Change | -18.41% |
3 Month Change | -13.33% |
1 Year Change | 63.02% |
3 Year Change | 23.34% |
5 Year Change | 139.66% |
Change since IPO | -62.11% |
Recent News & Updates
Recent updates
Shareholder Returns
500288 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -0.5% | 2.7% | 2.5% |
1Y | 63.0% | 63.9% | 47.3% |
Return vs Industry: 500288 matched the Indian Pharmaceuticals industry which returned 63.9% over the past year.
Return vs Market: 500288 exceeded the Indian Market which returned 47.3% over the past year.
Price Volatility
500288 volatility | |
---|---|
500288 Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500288's share price has been volatile over the past 3 months.
Volatility Over Time: 500288's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 1,649 | Sushil Suri | https://www.morepen.com |
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals.
Morepen Laboratories Limited Fundamentals Summary
500288 fundamental statistics | |
---|---|
Market cap | ₹21.50b |
Earnings (TTM) | ₹761.20m |
Revenue (TTM) | ₹16.42b |
28.2x
P/E Ratio1.3x
P/S RatioIs 500288 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
500288 income statement (TTM) | |
---|---|
Revenue | ₹16.42b |
Cost of Revenue | ₹10.73b |
Gross Profit | ₹5.69b |
Other Expenses | ₹4.93b |
Earnings | ₹761.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.49 |
Gross Margin | 34.65% |
Net Profit Margin | 4.64% |
Debt/Equity Ratio | 3.5% |
How did 500288 perform over the long term?
See historical performance and comparison